NEXT

Andrew Denney

Andrew Denney

Andrew Denney is the bureau chief for the New York Law Journal. He can be reached at [email protected]. Twitter: @messagetime

Connect with this author

August 08, 2017 | New York Law Journal

Shkreli Trial Was No 'Slam Dunk' for Prosecutors, Brafman Says

On Friday, former pharmaceutical executive Martin Shkreli, who faced eight counts in a securities fraud trial that lasted more than a month, was found guilty of three felony counts. But Benjamin Brafman, Shkreli's lead counsel and an attorney known for taking on famous—and, at times, infamous—clients like mob boss Salvatore "Sammy the Bull" Gravano, Sean Combs and Dominique Strauss-Kahn, says he's as proud of the outcome of the Shkreli case as he would be in a case in which his client won total acquittal.

By Andrew Denney

10 minute read

August 07, 2017 | New York Law Journal

US Chamber Group Says New Asbestos Docket Rules Tilt Field Toward Plaintiffs

As a Manhattan appeals court prepares to hear a challenge against a new case management order for New York City's asbestos docket, the U.S. Chamber of Commerce's tort reform arm has waded into the fight, arguing in a new report that the changes will tip the scales in plaintiffs' favor.

By Andrew Denney

3 minute read

August 04, 2017 | New York Law Journal

Shkreli Guilty on 3 of 8 Charges in Brooklyn Federal Court

After a six-week trial, a jury found former pharmaceutical executive Martin Shkreli guilty of three counts related to a scheme in which prosecutors said he defrauded investors into two hedge funds and paid them back by pilfering another company he formed.

By Andrew Denney

5 minute read

August 03, 2017 | New York Law Journal

Insurgent Slate Roils Brooklyn Judicial Elections

Of the 10 candidates vying for five of the open seats in Brooklyn Civil Court in the Sept. 12 Democratic primary, five are running as part of an insurgent slate that seeks to shake up a system that they say is under the thumb of the borough's Democratic establishment.

By Andrew Denney

11 minute read

August 02, 2017 | New York Law Journal

'Disturbing' False Arrest Claim by US Citizen Against ICE Time-Barred, Divided Panel Says

A U.S. citizen who was held in custody for more than three years under the mistaken belief he was deportable has lost his false imprisonment claim against immigration officials as untimely, a divided federal appeals court panel ruled.

By Andrew Denney

10 minute read

August 02, 2017 | New York Law Journal

GM's Bellwether Victory in NY May Not Predict Future of Ignition Switch Litigation

As General Motors is scheduled later this year to face yet another bellwether trial over allegations it covered up a deadly ignition switch flaw, it can take some comfort from its generally-successful trial record. But critics of the bellwether system are saying that way of lining up trials does not provide an accurate way of keeping score.

By Andrew Denney

4 minute read

August 01, 2017 | The American Lawyer

Big Suits

In re Anthem Data Breach Litigation Anthem Inc. has agreed to pay $115 million to settle claims related to the massive 2015 cyberattack that affected…

By Andrew Denney, Ross Todd and Jennifer Williams-Alvarez

7 minute read

August 01, 2017 | New York Law Journal

Shkreli Jurors Mark Second Day With Queries on Intent, Investment Term

Jurors in the Martin Shkreli securities fraud trial did not reach a verdict on Tuesday, the second day of deliberations, but issued their first substantive jury note, in which they asked the court to define "fraudulent intent" and the investment term "assets under management."

By Andrew Denney

2 minute read

July 31, 2017 | New York Law Journal

'Slack' Sandwich Pack Subject of Class Action Against Pret A Manger

For one patron to one of Manhattan's many Pret A Manger sandwich shops, a few inches of empty space in the packaging for the chain's wraps may be worth millions.

By Andrew Denney

3 minute read

July 28, 2017 | New York Law Journal

Shkreli's Fate Placed in Hands of Brooklyn Federal Jury

The question of whether "felon" will be another moniker attached to Martin Shkreli, a former pharmaceutical executive standing trial for securities and wire fraud who has been given the tongue-in-cheek nickname "Pharma Bro," was placed Friday in the hands of a federal jury in Brooklyn.

By Andrew Denney

3 minute read